Related Experiment Videos

Inhibition of yeast cytochrome P-450 by ammonium metavanadate

R Del Carratore1, E Morichetti, A Galli

  • 1Istituto di Mutagenesi e Differenziamento, CNR, Pisa, Italy.

Mutation Research
|March 1, 1993
PubMed

Insights

Ammonium metavanadate (AMV) inhibits the cytochrome P-450 system in yeast cells. This compound reduces both the protein and mRNA levels of cytochrome P-450, affecting its function.

Area of Science:

  • Biochemistry
  • Yeast Genetics
  • Enzymology

Background:

  • Cytochrome P-450 enzymes are crucial for cellular metabolism and detoxification.
  • Saccharomyces cerevisiae is a widely used model organism in biological research.
  • Understanding inhibitors of these systems is important for various applications.

Purpose of the Study:

  • To investigate the effect of ammonium metavanadate (AMV) on the cytochrome P-450-dependent monooxygenase system in Saccharomyces cerevisiae.
  • To determine the mechanisms by which AMV affects cytochrome P-450 levels and activity.

Main Methods:

  • Yeast cells (Saccharomyces cerevisiae, D7 strain) were incubated with ammonium metavanadate.
  • Enzyme activity assays (7-ethoxycoumarin O-deethylase) were performed.
  • Microsomal fractions were analyzed using electrophoresis.
  • Cytochrome P-450 transcript levels were analyzed.

Main Results:

  • AMV treatment led to a significant decrease in cytochrome P-450 levels and 7-ethoxycoumarin O-deethylase activity.
  • Electrophoretic analysis showed reduced protein bands in the 51,000-58,000 Da range in AMV-treated cells.
  • AMV significantly reduced the mRNA levels of cytochrome P-450.

Conclusions:

  • Ammonium metavanadate inhibits the yeast cytochrome P-450 system.
  • The inhibition occurs at both pre-transcriptional (mRNA level) and post-transcriptional (protein level) stages.
  • AMV serves as a valuable tool for studying yeast cytochrome P-450 regulation.

Related Concept Videos